Robin A. Fairhurst

2.1k total citations
49 papers, 1.2k citations indexed

About

Robin A. Fairhurst is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Robin A. Fairhurst has authored 49 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 21 papers in Organic Chemistry and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Robin A. Fairhurst's work include Receptor Mechanisms and Signaling (8 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and DNA and Nucleic Acid Chemistry (5 papers). Robin A. Fairhurst is often cited by papers focused on Receptor Mechanisms and Signaling (8 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and DNA and Nucleic Acid Chemistry (5 papers). Robin A. Fairhurst collaborates with scholars based in United Kingdom, Switzerland and United States. Robin A. Fairhurst's co-authors include Steven J. Charlton, Pascal Furet, Christine Fritsch, Giorgio Caravatti, Patricia Imbach‐Weese, Harry Heaney, Francesca Blasco, Mark Knapp, Ian C. Bruce and Joachim Blanz and has published in prestigious journals such as Journal of the American Chemical Society, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Robin A. Fairhurst

48 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robin A. Fairhurst United Kingdom	19	664	390	247	226	103	49	1.2k
Laurie Churchill United States	13	686 1.0×	260 0.7×	124 0.5×	208 0.9×	146 1.4×	20	1.3k
Minu Dutia United States	14	429 0.6×	336 0.9×	16 0.1×	184 0.8×	47 0.5×	21	908
Lori J. Pease United States	19	992 1.5×	381 1.0×	27 0.1×	51 0.2×	187 1.8×	26	1.5k
Vered Klinghofer United States	21	580 0.9×	372 1.0×	57 0.2×	288 1.3×	60 0.6×	27	1.3k
Clive McCarthy United Kingdom	16	255 0.4×	271 0.7×	99 0.4×	98 0.4×	50 0.5×	29	673
Sonia Lamontagne Canada	19	525 0.8×	314 0.8×	126 0.5×	302 1.3×	95 0.9×	22	1.3k
Yoshikazu Iwasawa Japan	23	1.3k 2.0×	433 1.1×	97 0.4×	281 1.2×	558 5.4×	68	2.0k
Roland Feifel Switzerland	21	769 1.2×	338 0.9×	28 0.1×	75 0.3×	206 2.0×	36	1.3k
Haile Tecle United States	14	1.1k 1.7×	423 1.1×	62 0.3×	40 0.2×	161 1.6×	27	1.7k
Peppi Prasit United States	21	592 0.9×	242 0.6×	162 0.7×	234 1.0×	39 0.4×	44	1.2k

Countries citing papers authored by Robin A. Fairhurst

Since Specialization

Citations

This map shows the geographic impact of Robin A. Fairhurst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin A. Fairhurst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin A. Fairhurst more than expected).

Fields of papers citing papers by Robin A. Fairhurst

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin A. Fairhurst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin A. Fairhurst. The network helps show where Robin A. Fairhurst may publish in the future.

Co-authorship network of co-authors of Robin A. Fairhurst

This figure shows the co-authorship network connecting the top 25 collaborators of Robin A. Fairhurst. A scholar is included among the top collaborators of Robin A. Fairhurst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin A. Fairhurst. Robin A. Fairhurst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ye, Ning, et al.. (2024). Development of a Safe and Efficient Continuous Flow Method for the Synthesis of 3‐Difluoromethoxypyridine Derivatives. Helvetica Chimica Acta. 108(2). 1 indexed citations

Sykes, David A., Mireia Jiménez‐Rosés, John Reilly, et al.. (2022). Exploring the kinetic selectivity of drugs targeting the β ₁ ‐adrenoceptor. Pharmacology Research & Perspectives. 10(4). 6 indexed citations

Fairhurst, Robin A., Thomas Knoepfel, Catherine Leblanc, et al.. (2017). Approaches to selective fibroblast growth factor receptor 4 inhibition through targeting the ATP-pocket middle-hinge region. MedChemComm. 8(8). 1604–1613. 31 indexed citations

Fairhurst, Robin A., Thomas H. Marsilje, Stefan Stutz, et al.. (2016). Optimisation of a 5-[3-phenyl-(2-cyclic-ether)-methyl-ether]-4-aminopyrrolopyrimidine series of IGF-1R inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(8). 2057–2064. 7 indexed citations

Fairhurst, Robin A., Giorgio Caravatti, Vito Guagnano, et al.. (2016). Increasing metabolic stability via the deuterium kinetic isotope effect: An example from a proline-amide-urea aminothiazole series of phosphatidylinositol-3 kinase alpha inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(19). 4729–4734. 1 indexed citations

Gerspacher, Marc, Robin A. Fairhurst, Robert Mah, et al.. (2015). Discovery of a novel tricyclic 4H-thiazolo[5′,4′:4,5]pyrano[2,3-c]pyridine-2-amino scaffold and its application in a PI3Kα inhibitor with high PI3K isoform selectivity and potent cellular activity. Bioorganic & Medicinal Chemistry Letters. 25(17). 3582–3584. 20 indexed citations

Fairhurst, Robin A., Marc Gerspacher, Patricia Imbach‐Weese, et al.. (2015). Identification and optimisation of 4,5-dihydrobenzo[1,2-d:3,4-d]bisthiazole and 4,5-dihydrothiazolo[4,5-h]quinazoline series of selective phosphatidylinositol-3 kinase alpha inhibitors. Bioorganic & Medicinal Chemistry Letters. 25(17). 3575–3581. 15 indexed citations

Fairhurst, Robin A., Patricia Imbach‐Weese, Marc Gerspacher, et al.. (2015). Identification and optimisation of a 4′,5-bisthiazole series of selective phosphatidylinositol-3 kinase alpha inhibitors. Bioorganic & Medicinal Chemistry Letters. 25(17). 3569–3574. 17 indexed citations

Sykes, David A., et al.. (2014). Observed Drug-Receptor Association Rates Are Governed by Membrane Affinity: The Importance of Establishing “Micro-Pharmacokinetic/Pharmacodynamic Relationships” at the β2-Adrenoceptor. Molecular Pharmacology. 85(4). 608–617. 79 indexed citations

10.

Beattie, David T., David Beer, Ian C. Bruce, et al.. (2012). An investigation into the structure–activity relationships associated with the systematic modification of the β2-adrenoceptor agonist indacaterol. Bioorganic & Medicinal Chemistry Letters. 22(19). 6280–6285. 24 indexed citations

11.

Beattie, David T., Steven J. Charlton, Bernard Cuenoud, et al.. (2010). A physical properties based approach for the exploration of a 4-hydroxybenzothiazolone series of β2-adrenoceptor agonists as inhaled long-acting bronchodilators. Bioorganic & Medicinal Chemistry Letters. 20(17). 5302–5307. 19 indexed citations

12.

Beattie, David T., Zarin Brown, Steven J. Charlton, et al.. (2009). Synthesis and evaluation of two series of 4′-aza-carbocyclic nucleosides as adenosine A2A receptor agonists. Bioorganic & Medicinal Chemistry Letters. 20(3). 1219–1224. 9 indexed citations

13.

Naline, Emmanuel, A. Trifilieff, Robin A. Fairhurst, Charles Advenier, & Mathiéu Molimard. (2006). Effect of indacaterol, a novel long-acting β₂-agonist, on isolated human bronchi. European Respiratory Journal. 29(3). 575–581. 81 indexed citations

14.

Battram, Cliff H., Steven J. Charlton, Bernard Cuenoud, et al.. (2006). In Vitro and in Vivo Pharmacological Characterization of 5-[(R)-2-(5,6-Diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1 H-quinolin-2-one (Indacaterol), a Novel Inhaled β2 Adrenoceptor Agonist with a 24-h Duration of Action. Journal of Pharmacology and Experimental Therapeutics. 317(2). 762–770. 128 indexed citations

15.

Beer, David, David Bentley, Ian Bruce, et al.. (2004). Long-chain formoterol analogues: an investigation into the effect of increasing amino-substituent chain length on the β2-adrenoceptor activity. Bioorganic & Medicinal Chemistry Letters. 14(18). 4705–4710. 32 indexed citations

16.

Fairhurst, Robin A., et al.. (2001). Stereochemical Assignment and Stereoselective Synthesis of 3′-C-P-N-5′ R _P-Ethyl Phosphonamidate Modified Nucleic Acid. Synlett. 2001(4). 473–476. 1 indexed citations

17.

Magnus, Philip, et al.. (1997). Synthetic and Mechanistic Studies on the Azabicyclo[7.3.1]enediyne Core and Naphtho[2,3-h]quinoline Portions of Dynemicin A. Journal of the American Chemical Society. 119(24). 5591–5605. 30 indexed citations

18.

Lynch, Vincent M., et al.. (1995). 4,7-Dimethoxybenzo[c]furan. Acta Crystallographica Section C Crystal Structure Communications. 51(4). 780–782. 2 indexed citations

19.

Lynch, Vincent M., et al.. (1995). Two [7.3.1]Azabicyclo-z-3-ene-1,5-diyne Analogues of Dynemicin A. Acta Crystallographica Section C Crystal Structure Communications. 51(4). 782–786. 2 indexed citations

20.

Magnus, Philip, et al.. (1994). Short synthesis of the dynemicin core structure: unusual bridgehead enolate reactivity. Journal of the Chemical Society Chemical Communications. 1543–1543. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact